Correspondence to "Effectiveness and safety of generic tofacitinib in spondyloarthritis: A real-world retrospective analysis from India"

Int J Rheum Dis. 2023 Dec;26(12):2587-2588. doi: 10.1111/1756-185X.14803. Epub 2023 Jun 28.

Authors

Ssu-Yu Chen¹, Ting-An Lin¹, Wen-Bin Yeh², Renin Chang³

Affiliations

¹ School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
² Department of Emergency Medicine, Kaohsiung Municipal Min-Sheng Hospital, Kaohsiung, Taiwan.
³ Department of Emergency Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.

PMID: 37377393
DOI: 10.1111/1756-185X.14803

No abstract available

Publication types

Letter

MeSH terms

Antirheumatic Agents* / adverse effects
Arthritis, Rheumatoid* / drug therapy
Humans
Retrospective Studies
Spondylarthritis* / diagnosis
Spondylarthritis* / drug therapy

Substances

tofacitinib
Antirheumatic Agents